HIBT Lab! Immunai: Noam Solomon

Hello and welcome to how I built this lab. I'm Guy Raz. So, if we've learned anything from our experience with COVID over the past few years, it's that we still have a lot to learn about how the human body fends off and fights disease. My guest today is on a mission to change that. In 2018, Noam Solomon and his co-founders launched a company called Immuni, and it's working to create what's essentially an atlas of the human immune system. There are thousands of clinical trials that take place each year around the world where people with certain diseases and conditions are given experimental medicine.

Immunei partners with hospitals and universities to gather cellular level data from those clinical trials. The company's massive computing power and artificial intelligence programs then analyze that data, which can then help figure out which experimental treatments work and which ones don't. Noel believes it eventually? Immunize technology can help pharmaceutical companies develop more effective treatments for some of the most serious diseases, including cancers. Immuni has offices in New York, Tel Aviv, and in Europe, and it's raised over$200 million for this work. Between them immunize founders with backgrounds in computer science, advanced mathematics, and biology.

Noam, the CEO, joined me from his office in Tel Aviv. So I knew I was going to be an academic uh even before I was ten years old. And the plan was to uh be a faculty member and uh doing research in I think computer science. Um

We already have this episode, so unlocking it is cheap and permanent: the full transcript, segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.

10 free credits is 10 episodes like this one a month. Episodes nobody has transcribed yet cost their length in hours, because we have to actually transcribe them.